PCV49 FINANCIAL IMPACT OF A NOVEL PREECLAMPSIA DIAGNOSTIC TEST VS. STANDARD CARE- A DECISION-ANALYTIC MODELING ANALYSIS FROM A GERMAN HEALTH CARE PAYER PERSPECTIVE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74576-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74576-9/fulltext
Title :
PCV49 FINANCIAL IMPACT OF A NOVEL PREECLAMPSIA DIAGNOSTIC TEST VS. STANDARD CARE- A DECISION-ANALYTIC MODELING ANALYSIS FROM A GERMAN HEALTH CARE PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74576-9&doi=10.1016/S1098-3015(10)74576-9
First page :
Section Title :
Open access? :
No
Section Order :
502